Chelsea Therapeutics International, Ltd. (CHTP) said Thursday that it plans to offer $20.0 million of its common stock in an underwritten public offering.
The company also plans to grant to the underwriters a 30-day option to purchase up to an additional 15% of the shares of common stock sold in the public offering to cover over-allotments, if any.
Leerink Swann LLC is acting as the sole book-running manager for the offering. Needham & Company, LLC and Roth Capital Partners, LLC are acting as the co-managers of the offering.
by RTT Staff Writer
For comments and feedback: firstname.lastname@example.org